Towards adherence monitoring using breath or oral fluid as a matrix in a methadone maintenance treatment program for patients with a chronic heroin use disorder: Issues and interpretation of the results.

Autor: de Jong LAA; Department of Clinical Pharmacy, Expert center Gelre-iLab, Gelre Hospitals, P.O. Box 9014, Apeldoorn 7300 DS, The Netherlands., Kloost T; Department of Clinical Pharmacy, Expert center Gelre-iLab, Gelre Hospitals, P.O. Box 9014, Apeldoorn 7300 DS, The Netherlands., Olyslager EJH; Department of Clinical Pharmacy, Expert center Gelre-iLab, Gelre Hospitals, P.O. Box 9014, Apeldoorn 7300 DS, The Netherlands., Böttcher M; Department of Toxicology, MVZ Medizinische Labore Dessau Kassel GmbH, Bauhüttenstr. 6, Dessau-Roßlau 06847, Germany., Wieferink JA; Department of Clinical Pharmacy, Expert center Gelre-iLab, Gelre Hospitals, P.O. Box 9014, Apeldoorn 7300 DS, The Netherlands., Vossenberg P; Tactus Addiction Treatment Center, P.O. Box 154, Deventer 7400 AD, The Netherlands., Belgers M; IrisZorg, Institute for Addiction Care and Sheltered Housing, Mr. B.M. Teldersstraat 7, Arnhem 6842 CT, The Netherlands., Beurmanjer H; Novadic-Kentron Addictioncare, Hogedwarsstraat 3, Vught AE 5261, The Netherlands.; Behavioural Science Institute, Radboud University Nijmegen, P.O. Box 9104, Nijmegen 6500 HE, The Netherlands., de Haan HA; Tactus Addiction Treatment Center, P.O. Box 154, Deventer 7400 AD, The Netherlands.

Publikováno v: Journal of analytical toxicology [J Anal Toxicol] 2023 Dec 12; Vol. 47 (9), pp. 842-849.